Skip to main content
Nanjing Vishee Medical Technology Co., Ltd. logo

Nanjing Vishee Medical Technology Co., Ltd. — Investor Relations & Filings

Ticker · 688580 ISIN · CNE1000041Q0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 664 across all filing types
Latest filing 2026-05-20 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 688580

About Nanjing Vishee Medical Technology Co., Ltd.

https://www.vishee.com/

Nanjing Vishee Medical Technology Co., Ltd. is a specialized medical technology enterprise focused on the research, development, and manufacturing of advanced neuro-rehabilitation equipment. The company primarily develops non-invasive brain stimulation technologies, with a core product line centered on Transcranial Magnetic Stimulation (TMS) and repetitive Transcranial Magnetic Stimulation (rTMS) systems. These solutions are designed for the clinical treatment of neurological and psychiatric conditions, including depression, stroke recovery, and cognitive impairment. By integrating clinical research with engineering innovation, the company provides diagnostic and therapeutic tools to hospitals, psychiatric centers, and rehabilitation facilities. Its portfolio emphasizes precision, safety, and efficacy in neuromodulation, supporting healthcare providers in delivering targeted interventions for brain-related disorders.

Recent filings

Filing Released Lang Actions
南京伟思医疗科技股份有限公司2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an official announcement of resolutions and detailed voting results from the 2025 Annual General Meeting of shareholders, including vote counts and percentages for each proposal. This matches the definition of a "Declaration of Voting Results & Voting Rights Announcements" (DVA). It is not the report itself but the formal record of shareholder vote outcomes at the AGM.
2026-05-20 Chinese
江苏世纪同仁律师事务所关于南京伟思医疗科技股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 85% confidence The document is a standalone legal opinion (“法律意见书”) issued by a law firm on the legality of the company’s 2025 annual shareholders meeting (AGM). It reviews convening procedures, voting methods, attendance, and vote results, but does not itself constitute an annual report, financial statements, or investor presentation. It is a compliance/legal filing rather than a financial or operational report. There is no dedicated category for legal opinions in the taxonomy, so under the fallback rules it should be classified as a Regulatory Filing (RNS).
2026-05-20 Chinese
南京伟思医疗科技股份有限公司关于变更办公及联系地址的公告
Regulatory Filings Classification · 91% confidence The document is a corporate announcement notifying investors of a change in the company’s office and contact address. It does not report financial results, governance rules, management changes, dividends, or other categorized events. It is a general regulatory announcement and thus falls under the fallback category “Regulatory Filings (RNS).”
2026-05-15 Chinese
南京伟思医疗科技股份有限公司2025年年度股东会会议资料
AGM Information Classification · 95% confidence The document is titled “2025年年度股东会会议资料” and contains detailed meeting instructions, agenda, and proposal materials (e.g., board work report, financial statements, profit distribution plan, auditor reappointment, remuneration schemes) for the 2025 Annual General Meeting of shareholders. It is not merely a notice or proxy but the full AGM presentation/material packet, matching the definition of AGM Information (AGM-R).
2026-05-11 Chinese
南京伟思医疗科技股份有限公司关于召开2025年度暨2026年第一季度业绩说明会的公告
Investor Presentation Classification · 80% confidence The document is an announcement by Nanjing Vishee Medical regarding the scheduling of a 2025 Annual and 2026 Q1 performance explanation meeting for investors. It lays out the time, location (online via SSE roadshow), participation method, and that the company will disclose the 2025 Annual Report and 2026 Q1 Report on April 28. This is not the actual financial report, not an earnings release, nor a transcript, but a notice of an investor-facing presentation/event. Therefore it best fits the Investor Presentation category (IP).
2026-04-14 Chinese
南京伟思医疗科技股份有限公司关于核心技术人员变更的公告
Board/Management Information Classification · 95% confidence The document is an announcement from a company about changes in its core technical personnel. It details the adjustment of responsibilities of a current core technical staff member and the recognition of a new core technical staff member. The document includes personal resumes, roles, and the impact of these changes on the company's operations and technology. There is no financial data, no mention of financial results, no regulatory certifications, or report attachments. The content is focused on management-level personnel changes specifically related to core technical staff, which aligns with announcements about changes in senior management or board members. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS. Hence, the classification is MANG with high confidence.
2026-04-02 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.